| Literature DB >> 34282904 |
Hyun Seung Lim1, Seong Keun Kim1, Seung-Gyun Woo1,2, Tae Hyun Kim1,2, Soo-Jin Yeom1,3, Wonshik Yong1, Yoon-Joo Ko4, Soo-Jung Kim1,5, Seung-Goo Lee1,2, Dae-Hee Lee1,2.
Abstract
(-)-α-Bisabolol is a functional ingredient in various health and cosmetic products and has antibacterial, anti-inflammatory, and wound healing properties. (-)-α-Bisabolol is chemically synthesized and produced by steam distillation of essential oils extracted from Brazilian Candeia (Eremanthus erythropappus). To sustainably produce pure (-)-α-bisabolol, we previously engineered Escherichia coli to produce 9.1 g/L (-)-α-bisabolol via heterologous mevalonate pathways and (-)-α-bisabolol synthase (BOS) from German chamomile, Matricaria recutita (MrBOS). BOS has only been reported in MrBOS and Brazilian Candeia (EeBOS). The limited availability of BOS has made it difficult to achieve high titer and yield and large-scale (-)-α-bisabolol production. We identified a novel BOS in globe artichoke (CcBOS) and examined its functionality in vitro and in vivo. CcBOS showed higher catalytic efficiency and (-)-α-bisabolol production rates than those from MrBOS or EeBOS. In fed-batch fermentation, CcBOS generated the highest reported (-)-α-bisabolol titer to date (23.4 g/L). These results may facilitate economically viable industrial (-)-α-bisabolol production.Entities:
Keywords: (−)-α-bisabolol; (−)-α-bisabolol synthase; Escherichia coli; artichoke; fermentation; mevalonate pathway
Mesh:
Substances:
Year: 2021 PMID: 34282904 DOI: 10.1021/acs.jafc.1c02759
Source DB: PubMed Journal: J Agric Food Chem ISSN: 0021-8561 Impact factor: 5.279